Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
by on Friday, August 31st, 2012 | No Comments
Condition: Dietary Carcinogenesis
Interventions: Drug: ACCS100; Drug: Placebo
Sponsors: Texas Enterosorbents Incorporated; Texas Enterosorbents Incorporated; Texas A&M University; University of Georgia; University of Texas
Recruiting – verified August 2012
Read the original here: Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"